Hyperlipidemia

Adults who contract COVID-19 have a higher risk for developing incident diabetes in the 90 days after the infection compared with before the infection, according to data published in JAMA Network Open.

Researchers observed a positive dose-response association between dietary cholesterol and type 2 diabetes incidence, particularly in Western countries, according to a meta-analysis of prospective cohort studies.

PHILADELPHIA — When analyzing patients with rheumatoid arthritis based on their comorbidities, certain groups experienced differing survival outcomes when compared with the expected mortality of the general population.

Treatment effect of the PCSK9 inhibitor alirocumab (Praluent, Sanofi/Regeneron) vs. sham control on LDL in patients with STEMI referred for primary PCI.

ANAHEIM, Calif. — Women with polycystic ovary syndrome are more likely to develop type 2 diabetes and may develop hypertension, diabetes and hyperlipidemia earlier than those without PCOS, according to a speaker.

The 2022 Cardiometabolic Health Congress will return in-person to Boston with the latest updates spanning all aspects of cardiometabolic health, including CVD, diabetes, kidney disease, lipid and lifestyle management and obesity.

BOSTON — PCSK9 inhibition before primary PCI for STEMI, on top of standard statin therapy, significantly lowered LDL at 6 weeks compared with sham control, according to the results of the EPIC-STEMI trial presented at TCT 2022.

The American College of Cardiology issued an expert consensus decision pathway to address new lipid-lowering agents and other developments since the release of the ACC/American Heart Association cholesterol guidelines in 2018.

Vupanorsen (Ionis) for reduction of non-HDL in patients with hyperlipidemia already on statin therapy.

Patients with aortic stenosis who received oral calcium supplementation had lower survival rates and were more likely to need aortic valve replacement than those who did not receive supplementation, according to recent data.